SCHLAGWORTE: Andeera Partners
Gilead Sciences to acquire Tubulis for up to $5 billion
US biopharmaceutical giant Gilead Sciences is acquiring the biotech start-up Tubulis, significantly expanding its oncology division. The transaction includes an upfront cash payment of...